ArticleVeterinary medicine and science2025
Evaluation of Antibacterial Activity of Trichilia dregeana Sond. (Meliaceae) Methanolic Extract Against Gram-Positive and Gram-Negative Bacteria.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Linking Phytochemical Diversity to Aflatoxin Suppression: LC-MS/MS Metabolomics ofMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medicinal plants have been playing a crucial role in drug discovery and development against infectious diseases. The antibacterial activity of methanolic crude extract of traditionally used Trichilia dregeana Sond. was evaluated against common bacterial pathogens. Agar well diffusion and broth dilution assays were used to evaluate the antimicrobial activity and minimum inhibitory concentration (MIC) of methanolic extract. The methanolic crude extract of Trichilia dregeana Sond. showed promising antibacterial activity against all tested bacterial isolates. A significant difference (p < 0.05) was observed in terms of susceptibility among Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa species isolates. A higher mean susceptibility or inhibition zone diameter to methanolic extract was observed in E. coli (19.6 ± 5.9 mm) and P. aeruginosa (18.4 ± 5.9 mm) compared to S. aureus isolates. Significant differences were also observed in the susceptibility of tested bacterial isolates at different concentrations of crude extract. A higher inhibition zone diameter was recorded in P. aeruginosa (27.2 ± 1.5 mm), followed by E. coli (25.2 ± 1.5 mm) and S. aureus (21.1 ± 1.4 mm) at a concentration of 100 mg/mL. A comparable inhibition zone of crude extract was observed with that of the positive control at a 100 mg/mL concentration against S. aureus and E. coli isolates. The findings indicated that bacterial growth inhibition increased as the concentration of the crude extract increased. All tested pathogenic bacterial species (Gram-positive and Gram-negative) were susceptible to plant leaf extract, even at lower levels of concentration. This showed the broad-spectrum activity of the plant extract against both Gram-positive and Gram-negative bacteria. The methanolic extract of plants is an effective antibacterial agent to treat bacterial infections since the extract showed significant antibacterial potency, comparable with that of the standard antibiotic disc. The findings are promising and encourage further investigation on the phytochemical, toxicological and pharmacological aspects of the crude extract to support their potential rational use in antimicrobial therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.